Stigmasterol was reported to participate in axon and dendrite development, the modulation of synaptic transmission [55], reduction of amyloidogenic amyloid precursor protein (APP) processing, inhibition of acetylcholine esterase, and amelioration of memory impairment [56]. The gene discussed is APP; the disease is memory impairment.